title: Toward the harmonization of immune monitoring in clinical trials: quo vadis?
authors.affiliation: Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands. cebritten@web.de
authors.forename: C M
authors.initials: CM
authors.lastname: Britten
authors.forename: S
authors.initials: S
authors.lastname: Janetzki
authors.forename: S H
authors.initials: SH
authors.lastname: van der Burg
authors.forename: C
authors.initials: C
authors.lastname: Gouttefangeas
authors.forename: A
authors.initials: A
authors.lastname: Hoos
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D007167:Immunotherapy; D015166:Monitoring, Immunologic / Q000592:standards*; D009369:Neoplasms / Q000628:therapy*; D011237:Predictive Value of Tests